Press Releases

Filter Releases
 
Press Releases
Date Title and Summary
May 7, 2015
MINNEAPOLIS, MN, May 7, 2015 - Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company primarily serving the urology market, will release financial results for the fourth quarter and fiscal year ended March 31, 2015 after the market close on Thursday, May 14, 2015. The Company will host a conference call and web...
Apr 1, 2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 31, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) today announced the completion of their merger. The merger was originally announced in December 2014, and completion of the all-stock combination creates a new medical device company named Cogentix Medical, Inc....
Mar 30, 2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies. "We are pleased with the outco...
Mar 30, 2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies. "We are pleased with the outco...
Mar 3, 2015
MINNEAPOLIS, March 3, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, will host a meeting for shareholders and analysts on Thursday, March 12, 2015, beginning at 3:00 pm Central Time, at Uroplasty's corporate headquart...
Feb 27, 2015
MINNEAPOLIS, Feb. 27, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that it will participate in the 27th Annual ROTH Conference on Tuesday, March 10, 2015. Rob Kill, President and CEO, and Brett Reyno...
Feb 24, 2015
MINNEAPOLIS, Feb. 24, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Cigna has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's Urgent...
Feb 4, 2015
ORANGEBURG, NY -- (Marketwired) -- 02/04/15 -- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products, today announced financial results for the three- and nine-month periods ended December 31, 2014. Third Quarter Fiscal 2015 Highlights Net sales increased 9% t...
Jan 22, 2015
ORANGEBURG, NY / ACCESSWIRE / January 22, 2015 / Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the third quarter fiscal 2015, ended December 31, 2014, after ...
Jan 22, 2015
MINNEAPOLIS, Jan. 22, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 third quarter ended December 31, 2014. Global revenue for the Company's Urgent® PC Neuromod...
Page: First Previous
...
 
= add release to Briefcase


View archived press releases from Vision-Sciences and Uroplasty